Physician profile
Robert S Singer
NPI 1952392839
$15,014.55
in general payments reported to CMS, 2019-2025
39 companies · $3,125 in 2025
The $3,125 reported for 2025 was more than what 85% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,648 · 2020: $1,152 · 2021: $1,573 · 2022: $1,993 · 2023: $2,293 · 2024: $3,232 · 2025: $3,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,642 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,641.52 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,287.37 | 2019-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $1,712.82 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Genzyme Corporation | $1,239.87 | 2019-2025 | |
| Pfizer INC. | $1,027.20 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,010.93 | 2019-2025 | Ilumya, Winlevi, Absorica Ld |
| Regeneron Healthcare Solutions, INC. | $1,000.98 | 2019-2025 | Dupixent, Libtayo |
| Incyte Corporation | $964.15 | 2021-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $961.17 | 2019-2025 | |
| Leo Pharma INC. | $615.41 | 2019-2025 | Adbry |
| Lilly USA, LLC | $577.11 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $473.42 | 2019-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $437.61 | 2019-2025 | Nemluvio, Aklief |
| Amgen INC. | $420.90 | 2019-2025 | Otezla, Otezla, Enbrel |
| E.R. Squibb & Sons, L.L.C. | $315.63 | 2021-2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $284.10 | 2019-2024 | Cabtreo, Jublia, Arazlo |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.